- Report
- November 2024
- 141 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2024
- 127 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2023
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Poland
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2023
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2022
- 171 Pages
Global
From €3249EUR$3,570USD£2,785GBP
The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body.
The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products.
Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more